Summary

The body contouring devices market is projected to reach USD 3.00 Billion by 2029 from USD 1.74 Billion in 2024, at a CAGR of 11.4% during the forecast period. Market expansion is propelled by factors such as the growing utilization of non-invasive body contouring devices, increase in the advertisement of aesthetic procedures on social media and easily accessible clinics andbeauty centers for these procedures. Conversely, significant market consolidation among key players and the need for substantial capital investments pose notable obstacles to market growth.
“Non-invasive segment accounted for the highest CAGR.”
By product, the market is primarily segmented into non-invasive and invasive. The non-invasive segment accounted for the highest growth rate of the body contouring devices in 2023. The substantial increase in market growth can be primarily attributed to the extensive utilization of both non-invasive and minimally invasive body contouring devices. Furthermore, advancements in the technology of application such as fat reduction and body tonning instruments and the growing demand for aesthetic and plastic surgeries are driving the expansion of this sector.
“The fat reduction segment accounted for the market share in the body contouring devices market, byapplication, during the forecast period.”
Byapplication, the market is primarily segmented into body toning and sculpting, fat reduction, cellulite treatment and skin tighteing. In 2023, non-robotic surgery accounted for the highest share of this market. The main factors propelling the growth of the market are the cost effective procedures for fat reduction, increase use of technologies like radiofrequency and lasers that provides least risk risingmiddle aged population. Additionally, surgeons preference of fat reduction devices over the slow weight loss process, contributing to their continued prominence in the market.
“Between 35 to 50 years segment accounted for the highest growth rate.”
By age group , the market is primarily segmented into between 35to 50 years, above 50 years and below 35 years . The between 30 to 50 years segment accounted for the highest growth rate of the body contouring devices age group market in 2023. The primary drivers of growth in this market are increase in obese population among the middle age population, increase competition among this age group population to look aesthetic and increase in advertisement of the body contouring procedures over social media.
“Female segment accounted for the largest market share.”
By gender , the market is primarily segmented into female and male . The female segment accounted for the highest share of the body contouring devices gender market in 2023. Easy accessibility of the body contouring devices and procedures, increased adoption of the body changes by female for aesthetic appearance and improved technologically advanced procedures with lowest downtime are the major reasons attributing to the largest share of the gender body contouring devices market.
“Specialty clinics segment accounted for the highest share.”
By end user, the market is primarily segmented into hospitals, specialty clinics and medical spas and beauty centers. The specialty clinics segment accounted for a larger share of the body contouring devices market in 2023. This can be credited to the significant volume of non-invasive surgical procedures carried out inspecialty clinics, facilitated by the presence of highly skilled healthcare professionals.
“Asia Pacific: The fastest-growing region in body contouring devices market.”
The global body contouring devices market is segmented into North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa and GCC Countries. Various factors are contributing to the growth of the market in the Asia-Pacific (APAC) region, including escalating healthcare expenditure, increase in medical tourism in the regions like China, India, Vietnam, rising per capita income, expansion of private-sector healthcare facilities into rural areas across several APAC nations and the existence of high-growth markets in the region. Moreover, the advantageous regulatory landscape and low costs in this region are anticipated to further drive market expansion.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level (30%), Director-level (20%), and Others (50%)
• By Region: North America (42%), Europe (31%), Asia- Pacific (20%), Latin America (4%), Middle East & Africa(2%) and GCC Countries (1%)
Lists of Companies Profiled in the Report:
• Abbvie, Inc. (US)
• Cutera (US)
• Bausch Health Companies Inc. (Canada)
• InMode Ltd. (Israel)
• Venus Concept (Canada)
• ENDYMED Medical (US)
• Cynosure Lutronic (US)
• Lumenis BE Ltd. (Israel)
• Alma Lasers (Israel)
• Candela Corporation (US)
• BTL Aesthetics Ltd. (UK)
• MicroAire Surgical Instruments LLC (US)
• Fotona (Slovenia)
• Nouvag AG (Switzerland)
• Erchonia Corporation (US)
• Konmison (China)
• Skinnovation Pvt. Ltd. (India)
• 3D Aesthetics (UK)
• Zimmer MedizinSystems Gmbh (Germany)
• Rohrer Aesthetics (US)
• Skin Aesthetics (India)
• SharpLight Technologies Inc. (Israel)
• Sebbin (France)
• Deka M.E.L.A. S.R.L. (Italy)
• INDIBA (Spain)
Research Coverage
This research report categorizes the body contouring devices market by product, application, age group, gender, end-user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the body contouring devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview; key strategies; product launch, approval, acquisition, merger and recent developments associated with the body contouring devices market. Competitive analysis of upcoming startups in the body contouring devices market ecosystem is covered in this report.
Reasons to buy this report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall body contouring devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
Analysis of key drivers (Growing adoption of minimally invasive and noninvasive aesthetic procedures), restraints (High cost of treatment and lack of reimbursement), opportunities (Improving healthcare infrastructure in emerging markets), and challenges (Stringent regulatory compliance and safety standards) influencing the growth of the body contouring devices market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the body contouring devices market
• Market Development: Comprehensive information about lucrative markets – the report analyses the body contouring devices market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the body contouring devices market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Abbvie, Inc. (US), Cutera (US), Bausch Health Companies Inc. (Canada), InMode Ltd. (Israel), Venus Concept (Canada) among others in body contouring devices market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.3 INCLUSIONS & EXCLUSIONS 30
1.4 STUDY SCOPE 31
1.4.1 BODY CONTOURING DEVICES MARKET 31
1.4.2 YEARS CONSIDERED 32
1.4.3 CURRENCY CONSIDERED 32
1.5 MARKET STAKEHOLDERS 32
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
2.1.1 SECONDARY DATA 34
2.1.1.1 Key data from secondary sources 34
2.1.2 PRIMARY DATA 35
2.1.2.1 Primary sources 36
2.1.2.2 Key data from primary sources 36
2.1.2.3 Key industry insights 37
2.1.2.4 Breakdown of primary interviews 38
2.2 MARKET SIZE ESTIMATION 39
2.2.1 BOTTOM-UP APPROACH 39
2.2.1.1 Approach 1: Company revenue estimation approach 39
2.2.1.2 Approach 2: Presentations of companies and primary interviews 40
2.2.1.3 CAGR projections 40
2.2.2 TOP-DOWN APPROACH 40
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 42
2.4 MARKET SHARE ESTIMATION 43
2.5 ASSUMPTIONS & LIMITATIONS 43
2.5.1 GROWTH RATE ASSUMPTIONS 43
2.5.2 LIMITATIONS 44
2.6 RISK ASSESSMENT 44
3 EXECUTIVE SUMMARY 45
4 PREMIUM INSIGHTS 50
4.1 BODY CONTOURING DEVICES MARKET OVERVIEW 50
4.2 BODY CONTOURING DEVICES MARKET SHARE, BY TYPE, 2024 VS. 2029 51
4.3 BODY CONTOURING DEVICES MARKET SHARE, BY APPLICATION, 2024 VS. 2029 51
4.4 BODY CONTOURING DEVICES MARKET SHARE, BY AGE GROUP, 2024 VS. 2029 52
4.5 BODY CONTOURING DEVICES MARKET SHARE, BY GENDER, 2024 VS. 2029 53
4.6 BODY CONTOURING DEVICES MARKET SHARE, BY END USER, 2024 VS. 2029 53
4.7 BODY CONTOURING DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
5.2.1 DRIVERS 56
5.2.1.1 Growing adoption of minimally invasive and non-invasive aesthetic procedures 56
5.2.1.2 Increasing awareness and acceptance of body contouring 57
5.2.1.3 Increasing demand for aesthetic treatments among men 58
5.2.1.4 Technological advancements 58
5.2.2 RESTRAINTS 59
5.2.2.1 High cost of treatment and lack of reimbursement 59
5.2.3 OPPORTUNITIES 60
5.2.3.1 Improving healthcare infrastructure in emerging markets 60
5.2.4 CHALLENGES 61
5.2.4.1 Stringent regulatory compliance and safety standards 61
5.2.4.2 Social and cultural barriers in emerging economies 62
5.3 PRICING ANALYSIS 62
5.3.1 INDICATIVE PRICING MODEL ANALYSIS OF MARKET PLAYERS 62
5.3.2 AVERAGE SELLING PRICE OF BODY CONTOURING DEVICES, BY REGION 63
5.4 PATENT ANALYSIS 65
5.4.1 LIST OF MAJOR PATENTS 66
5.5 VALUE CHAIN ANALYSIS 66
5.6 SUPPLY CHAIN ANALYSIS 68
5.7 TRADE ANALYSIS 69
5.7.1 TRADE ANALYSIS FOR LASER AESTHETIC DEVICES 69
5.8 ECOSYSTEM ANALYSIS 70
5.8.1 BODY CONTOURING DEVICES MARKET: ROLE IN ECOSYSTEM 71
5.9 PORTER’S FIVE FORCES ANALYSIS 72
5.9.1 THREAT OF NEW ENTRANTS 73
5.9.2 THREAT OF SUBSTITUTES 73
5.9.3 BARGAINING POWER OF BUYERS 73
5.9.4 BARGAINING POWER OF SUPPLIERS 73
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 73
5.10 REGULATORY LANDSCAPE 73
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
5.10.2 REGULATORY ANALYSIS 75
5.10.2.1 North America 75
5.10.2.1.1 US 75
5.10.2.1.2 Canada 76
5.10.2.2 Europe 76
5.10.2.3 Asia Pacific 77
5.10.2.3.1 China 77
5.10.2.3.2 Japan 78
5.10.2.3.3 India 78
5.10.2.4 Latin America 78
5.10.2.4.1 Brazil 78
5.10.2.4.2 Mexico 79
5.10.2.5 Middle East 79
5.11 TECHNOLOGY ANALYSIS 80
5.11.1 KEY TECHNOLOGIES 80
5.11.1.1 Cryolipolysis 80
5.11.1.2 Radiofrequency (RF) 80
5.11.1.3 High-intensity-focused Ultrasound (HIFU) 80
5.11.2 COMPLEMENTARY TECHNOLOGIES 80
5.11.2.1 Laser-assisted devices 80
5.11.2.2 Implants 80
5.11.3 ADJACENT TECHNOLOGIES 80
5.11.3.1 Body sculpting rollers 80
5.11.3.2 Electrostimulation devices 80
5.12 KEY CONFERENCES & EVENTS IN 2024–2025 81
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81
5.13.1 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 82
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 82
5.14.2 BUYING CRITERIA 84
5.15 INVESTMENT & FUNDING SCENARIO 85
5.16 IMPACT OF AI ON BODY CONTOURING DEVICES MARKET 85
6 BODY CONTOURING DEVICES MARKET, BY TYPE 86
6.1 INTRODUCTION 87
6.2 NON-INVASIVE DEVICES 87
6.2.1 RADIOFREQUENCY (RF) DEVICES 91
6.2.1.1 Ability to deliver noticeable results with minimal downtime to drive market growth 91
6.2.2 CRYOLIPOLYSIS/FAT FREEZING DEVICES 94
6.2.2.1 Risk associated with fat freezing to challenge market growth 94
6.2.3 HIGH-INTENSITY-FOCUSED ULTRASOUND (HIFU) DEVICES 97
6.2.3.1 Minimal downtime of HIFU devices to support adoption 97
 
6.2.4 LOW-LEVEL LASER THERAPY (LLLT) DEVICES 100
6.2.4.1 Increased patient safety and quick results to support market growth 100
6.2.5 OTHER NON-INVASIVE DEVICES 103
6.3 INVASIVE DEVICES 106
6.3.1 LIPOSUCTION DEVICES 109
6.3.1.1 Increasing obese population to drive growth 109
6.3.2 LASER-ASSISTED DEVICES 114
6.3.2.1 Shift towards minimally invasive aesthetic treatments to drive growth 114
6.3.3 IMPLANTS/FILLERS 117
6.3.3.1 Rising demand for cosmetic implants to fuel growth 117
7 BODY CONTOURING DEVICES MARKET, BY APPLICATION 121
7.1 INTRODUCTION 122
7.2 FAT REDUCTION 122
7.2.1 INCREASING NUMBER OF NON-INVASIVE AND MINIMALLY INVASIVE AESTHETIC PROCEDURES TO PROPEL MARKET GROWTH 122
7.3 SKIN TIGHTENING 125
7.3.1 INTRODUCTION OF CUTTING-EDGE DEVICES TO FUEL UPTAKE 125
7.4 BODY TONING & SCULPTING 128
7.4.1 INCREASED CONSUMER DESIRE FOR ENHANCED BODY AESTHETICS TO DRIVE MARKET GROWTH 128
7.5 CELLULITE TREATMENT 131
7.5.1 ADVANTAGES ASSOCIATED WITH ROBOTIC-ASSISTED SURGERY TO BOOST MARKET GROWTH 131
8 BODY CONTOURING DEVICES MARKET, BY AGE GROUP 135
8.1 INTRODUCTION 136
8.2 BETWEEN 35 TO 50 YEARS 136
8.2.1 GROWING INTEREST IN MAINTAINING YOUTHFUL APPEARANCE TO DRIVE MARKET GROWTH 136
8.3 ABOVE 50 YEARS 139
8.3.1 GROWING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN ACCEPTANCE OF COSMETIC PROCEDURES TO BOOST MARKET 139
8.4 BELOW 35 YEARS 142
8.4.1 INCREASING NUMBER OF CUSTOMIZABLE TREATMENT PLANS TO FAVOR MARKET GROWTH 142
9 BODY CONTOURING DEVICES MARKET, BY GENDER 146
9.1 INTRODUCTION 147
9.2 WOMEN 147
9.2.1 INCREASED AWARENESS AND ACCESSIBILITY OF BODY CONTOURING PROCEDURES TO DRIVE MARKET GROWTH 147
9.3 MEN 150
9.3.1 INCREASING ACCEPTANCE OF AESTHETIC PROCEDURES AMONG MEN TO BOOST UPTAKE 150
10 BODY CONTOURING DEVICES MARKET, BY END USER 154
10.1 INTRODUCTION 155
10.2 SPECIALTY CLINICS 155
10.2.1 OPERATIONAL ENHANCEMENTS, COMBINED WITH TARGETED MARKETING STRATEGIES, TO PROPEL MARKET 155
10.3 MEDICAL SPAS & BEAUTY CENTERS 158
10.3.1 AVAILABILITY OF MEDICAL TREATMENT IN COMFORTABLE AND RELAXING SETTINGS TO AID MARKET GROWTH 158
10.4 HOSPITALS 161
10.4.1 GROWING ADOPTION OF MINIMALLY INVASIVE PROCEDURES IN HOSPITALS TO SUPPORT MARKET GROWTH 161
11 BODY CONTOURING DEVICES MARKET, BY REGION 165
11.1 INTRODUCTION 166
11.2 NORTH AMERICA 166
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 171
11.2.2 US 172
11.2.2.1 Increased demand for aesthetic procedures to drive market growth 172
11.2.3 CANADA 175
11.2.3.1 Rapid increase in geriatric population and increased awareness about non-invasive body contouring procedures to boost market 175
11.3 EUROPE 179
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 183
11.3.2 GERMANY 183
11.3.2.1 Rising disposable incomes to boost use of body contouring devices 183
11.3.3 UK 187
11.3.3.1 Reduced stigma for body contouring procedures to drive market growth 187
11.3.4 FRANCE 190
11.3.4.1 Improved standard of living and growing disposable income to support market growth 190
11.3.5 ITALY 194
11.3.5.1 Increasing number of plastic surgeons to favor market growth 194
11.3.6 SPAIN 197
11.3.6.1 Increasing demand for cosmetic procedures and rising availability of safe minimally invasive technology to fuel growth 197
11.3.7 REST OF EUROPE 201
11.4 ASIA PACIFIC 204
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 210
11.4.2 CHINA 211
11.4.2.1 Growing availability of body contouring surgery to drive market 211
11.4.3 JAPAN 214
11.4.3.1 Increasing number of plastic surgeons to propel market growth in Japan 214
11.4.4 INDIA 218
11.4.4.1 Increasing disposable incomes to drive market growth in India 218
11.4.5 REST OF ASIA PACIFIC 221
11.5 LATIN AMERICA 225
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 229
11.5.2 BRAZIL 230
11.5.2.1 Growing focus on medical tourism to drive market growth 230
11.5.3 MEXICO 233
11.5.3.1 Growing volume of surgical procedures to aid market growth 233
11.5.4 REST OF LATIN AMERICA 237
11.6 MIDDLE EAST & AFRICA 240
11.6.1 IMPLEMENTATION OF FAVORABLE INITIATIVES TO BOOST MARKET 240
11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 244
11.7 GCC COUNTRIES 244
11.7.1 HIGHER DISPOSABLE INCOMES TO SUPPORT MARKET GROWTH 244
11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 248
12 COMPETITIVE LANDSCAPE 249
12.1 OVERVIEW 249
12.2 KEY PLAYER STRATEGY/RIGHT TO WIN 249
12.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN BODY CONTOURING DEVICES MARKET 249
12.3 REVENUE ANALYSIS, 2019–2023 251
12.4 MARKET SHARE ANALYSIS, 2023 251
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 253
12.5.1 LIST OF EVALUATED VENDORS 253
12.5.2 STARS 253
12.5.3 EMERGING LEADERS 253
12.5.4 PERVASIVE PLAYERS 253
12.5.5 PARTICIPANTS 253
12.5.6 COMPANY FOOTPRINT: KEY PLAYERS, 2023 255
12.5.6.1 Company footprint 255
12.5.6.2 Type footprint 255
12.5.6.3 Application footprint 256
12.5.6.4 Region footprint 256
12.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023 257
12.6.1 PROGRESSIVE COMPANIES 257
12.6.2 RESPONSIVE COMPANIES 257
12.6.3 DYNAMIC COMPANIES 257
12.6.4 STARTING BLOCKS 257
12.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023 258
 
12.7 COMPANY VALUATION & FINANCIAL METRICS 259
12.7.1 FINANCIAL METRICS 259
12.7.2 COMPANY VALUATION 260
12.8 BRAND/PRODUCT COMPARISON 261
12.8.1 ABBVIE, INC. 262
12.8.2 CYNOSURE LUTRONIC 262
12.8.3 CUTERA 262
12.9 COMPETITIVE SCENARIO 262
12.9.1 PRODUCT LAUNCHES & APPROVALS 262
12.9.2 DEALS 263
13 COMPANY PROFILES 264
13.1 KEY PLAYERS 264
13.1.1 ABBVIE, INC. 264
13.1.1.1 Business overview 264
13.1.1.2 Products offered 265
13.1.1.3 Recent developments 266
13.1.1.3.1 Product launches & approvals 266
13.1.1.3.2 Deals 267
13.1.1.4 MnM view 267
13.1.1.4.1 Right to win 267
13.1.1.4.2 Strategic choices 267
13.1.1.4.3 Weaknesses & competitive threats 267
13.1.2 INMODE LTD. 268
13.1.2.1 Business overview 268
13.1.2.2 Products offered 269
13.1.2.3 MnM view 270
13.1.2.3.1 Right to win 270
13.1.2.3.2 Strategic choices 270
13.1.2.3.3 Weaknesses & competitive threats 270
13.1.3 BAUSCH HEALTH COMPANIES INC. 271
13.1.3.1 Business overview 271
13.1.3.2 Products offered 272
13.1.3.3 Recent developments 273
13.1.3.3.1 Product approvals 273
13.1.3.4 MnM view 273
13.1.3.4.1 Right to win 273
13.1.3.4.2 Strategic choices 273
13.1.3.4.3 Weaknesses & competitive threats 273
 
13.1.4 CYNOSURE LUTRONIC 274
13.1.4.1 Business overview 274
13.1.4.2 Products offered 275
13.1.4.3 MnM view 276
13.1.4.3.1 Right to win 276
13.1.4.3.2 Strategic choices 276
13.1.4.3.3 Weaknesses & competitive threats 276
13.1.5 CUTERA, INC. 277
13.1.5.1 Business overview 277
13.1.5.2 Products offered 278
13.1.5.3 Recent developments 279
13.1.5.3.1 Product launches 279
13.1.5.4 MnM view 279
13.1.5.4.1 Right to win 279
13.1.5.4.2 Strategic choices 279
13.1.5.4.3 Weaknesses & competitive threats 279
13.1.6 VENUS CONCEPT 280
13.1.6.1 Business overview 280
13.1.6.2 Products offered 281
13.1.6.3 Recent developments 282
13.1.6.3.1 Product launches & approvals 282
13.1.7 ENDYMED MEDICAL 283
13.1.7.1 Business overview 283
13.1.7.2 Products offered 283
13.1.8 LUMENIS BE LTD. 284
13.1.8.1 Business overview 284
13.1.8.2 Products offered 284
13.1.9 ALMA LASERS 285
13.1.9.1 Business overview 285
13.1.9.2 Products offered 285
13.1.10 CANDELA CORPORATION 287
13.1.10.1 Business overview 287
13.1.10.2 Products offered 287
13.1.10.3 Recent developments 288
13.1.10.3.1 Product launches 288
13.2 OTHER PLAYERS 289
13.2.1 BTL AESTHETICS LTD. 289
13.2.2 MICROAIRE SURGICAL INSTRUMENTS, LLC 290
13.2.3 FOTONA 291
13.2.4 NOUVAG AG 292
13.2.5 ERCHONIA CORPORATION 292
13.2.6 KONMISON 293
13.2.7 SKINNOVATION PVT. LTD. 294
13.2.8 3D AESTHETICS 295
13.2.9 ZIMMER MEDIZINSYSTEME GMBH 296
13.2.10 ROHRER AESTHETICS 297
13.2.11 SKIN AESTHETICS 297
13.2.12 SHARPLIGHT TECHNOLOGIES INC. 298
13.2.13 SEBBIN 299
13.2.14 DEKA M.E.L.A. S.R.L. 300
13.2.15 INDIBA 301
14 APPENDIX 302
14.1 DISCUSSION GUIDE 302
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 306
14.3 CUSTOMIZATION OPTIONS 308
14.4 RELATED REPORTS 308
14.5 AUTHOR DETAILS 309